Live Breaking News & Updates on Ocular Immunology

Stay updated with breaking news from Ocular immunology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Roivant Sciences : NIU Phase 2 Topline Results -April 02, 2024 at 08:48 am EDT

NIU Phase 2 Topline Results and Corporate Updates

April 2024

Forward-Looking Statements

Forward-Looking Statements
. ....

United States , Roivant Priovant , Demyelinating Polyneuropathy Immunovant , Dermatomyositis Priovant , Gravis Immunovant , Exchange Commission , Capital Allocation , Positive Results , Share Repurchase Program Including Purchase , Entire Sumitomo Stake , Reducing Share Count , Next Chapter , Robust Late Stage , Eye Disease , Inflammatory Demyelinating Polyneuropathy , Infectious Uveitis , Treatment Failure , Potential Large Orphan , Unmet Need , Commercial Opportunity , Manfred Zierhut , Vision Loss , Ocular Immunology , Clin Exp Rheum ,

Pearce IP BioBlast w/e 8 March 2024

On 9 March 2024, Samsung Bioepis presented two papers of study results for its immunology portfolio at the 2024 American Academy of Dermatology (AAD)… ....

United States , United Kingdom , San Diego , Ustekinumab Biosimilars , Coherus Biosciences , Tocilizumab Biosimilar , Samsung Bioepis , Novo Nordisk Ozempic , Darzalex Faspro , Fresenius Kabi Tyenne , Janssen Stelara , Genentech Roche Actemra , Bristol Myers Squibb Opdivo , Bayer Eylea , Amgen Xgeva , Denosumab Biosimilars , Sandoz Wyost , Novo Nordisk Wegovy , American Academy Of Dermatology , Us District Court , Health Canada , European Medical Agency , Novo Nordisk , Novo Holdings Nordisk , Nature Communications , Annual Meeting ,

Gout Therapeutics Market to be Worth $4.13 Billion by 2030: Grand View Research, Inc.

/PRNewswire/ The global gout therapeutics market size is expected to reach USD 4.13 billion by 2030 and expand at a CAGR of 6.25% from 2023 to 2030,. ....

United States , San Francisco , Saudi Arabia , Grand View , United Kingdom , South Korea , South Africa , Sherry James , Asia Pacific , View Research Pharmaceuticals , View Research , Takeda Pharmaceutical Company Ltd , Teijin Pharma Ltd , Merck Co , Teijin Ltd , Gout For National Kidney Month , Glaxosmithkline Plc , Uveitis Foundation , View Research Helps Fortune , View Research Inc , Selecta Biosciences Inc , Zydus Group , Regeneron Pharmaceuticals Inc , Arrowhead Pharmaceuticals , Jiangsu Hengrui Medicine Co Ltd , Grand View Research ,

SightMD Connecticut Welcomes Shimy Apoorva, DO to its expert team

Hauppauge, NY (PRWEB) July 17, 2023 SightMD Connecticut, a leading multi-specialty ophthalmology platform in Connecticut, welcomes Shimy Apoorva, DO to ....

United States , New York , Stephenc Foster , Shimy Apoorva , Fichman Eye Center , American Osteopathic Association , American Uveitis Society , Surgery Center , Episcopal Hospital Far Rockaway , Ocular Immunology , American Osteopathic , Franc Galinanes , Eye Center , Growth Partners , Press Release ,

Prevalence and Risk Factors of Dry Eye Disease

Laura Periman, MD, discusses the prevalence and risk factors of dry eye disease. ....

Laura Periman , Dry Eye Disease , Risk Factors , Dry Eye , Ocular Surface , Chronic Surface Disease , Blurry Vision , Surface Drop Load , Ocular Immunology ,